A detailed history of Schwartz Investment Counsel Inc transactions in Haemonetics Corp stock. As of the latest transaction made, Schwartz Investment Counsel Inc holds 151,000 shares of HAE stock, worth $11.4 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
151,000
Previous 151,000 -0.0%
Holding current value
$11.4 Million
Previous $12.5 Million 2.86%
% of portfolio
0.47%
Previous 0.5%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$71.24 - $85.35 $2.28 Million - $2.73 Million
32,000 Added 26.89%
151,000 $12.9 Million
Q3 2023

Oct 17, 2023

SELL
$82.56 - $93.49 $3.3 Million - $3.74 Million
-40,000 Reduced 25.16%
119,000 $10.7 Million
Q1 2023

May 08, 2023

SELL
$72.75 - $90.6 $1.82 Million - $2.27 Million
-25,000 Reduced 13.59%
159,000 $13.2 Million
Q3 2022

Nov 10, 2022

SELL
$63.3 - $78.66 $316,500 - $393,300
-5,000 Reduced 2.65%
184,000 $13.6 Million
Q1 2022

May 12, 2022

BUY
$43.77 - $63.22 $2.23 Million - $3.22 Million
51,000 Added 36.96%
189,000 $11.9 Million
Q4 2021

Feb 08, 2022

BUY
$49.55 - $74.59 $1.39 Million - $2.09 Million
28,000 Added 25.45%
138,000 $7.32 Million
Q3 2021

Nov 10, 2021

BUY
$57.6 - $70.59 $1.15 Million - $1.41 Million
20,000 Added 22.22%
110,000 $7.77 Million
Q2 2021

Aug 12, 2021

BUY
$51.81 - $118.56 $1.55 Million - $3.56 Million
30,000 Added 50.0%
90,000 $6 Million
Q4 2020

Feb 12, 2021

BUY
$88.75 - $119.95 $887,500 - $1.2 Million
10,000 Added 20.0%
60,000 $7.13 Million
Q3 2020

Nov 17, 2020

BUY
$75.65 - $93.58 $1.89 Million - $2.34 Million
25,000 Added 100.0%
50,000 $4.36 Million
Q2 2020

Aug 10, 2020

BUY
$84.96 - $118.91 $2.12 Million - $2.97 Million
25,000 New
25,000 $2.24 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.87B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Schwartz Investment Counsel Inc Portfolio

Follow Schwartz Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schwartz Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Schwartz Investment Counsel Inc with notifications on news.